Healthcare provider profile · identity verified

Kimberly K Heller, MD

Family Practice · SAN ANTONIO, TX · NPI 1629068697

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	778	201
Rosuvastatin Calcium	Rosuvastatin Calcium	557	164
Atorvastatin Calcium	Atorvastatin Calcium	376	106
Amlodipine Besylate	Amlodipine Besylate	341	95
Losartan Potassium	Losartan Potassium	332	87
Simvastatin	Simvastatin	324	85
Metoprolol Succinate	Metoprolol Succinate	271	77
Lisinopril	Lisinopril	259	75
Alendronate Sodium	Alendronate Sodium	219	65
Escitalopram Oxalate	Escitalopram Oxalate	186	51
Gabapentin	Gabapentin	186	55
Jardiance	Empagliflozin	171	33
Montelukast Sodium	Montelukast Sodium	168	47
Ozempic	Semaglutide	159	30
Pantoprazole Sodium	Pantoprazole Sodium	137	42
Estradiol	Estradiol	136	59
Pravastatin Sodium	Pravastatin Sodium	129	36
Sertraline Hcl	Sertraline Hcl	126	28
Olmesartan Medoxomil	Olmesartan Medoxomil	125	37
Ezetimibe	Ezetimibe	124	42
Metformin Hcl Er	Metformin Hcl	123	39
Hydrochlorothiazide	Hydrochlorothiazide	122	40
Zolpidem Tartrate	Zolpidem Tartrate	106	38
Citalopram Hbr	Citalopram Hydrobromide	99	28
Venlafaxine Hcl Er	Venlafaxine Hcl	98	23
Famotidine	Famotidine	96	24
Metformin Hcl	Metformin Hcl	96	26
Trazodone Hcl	Trazodone Hcl	93	22
Meloxicam	Meloxicam	92	31
Omeprazole	Omeprazole	92	27
Alprazolam	Alprazolam	89	30
Potassium Chloride	Potassium Chloride	87	24
Telmisartan	Telmisartan	85	21
Synthroid	Levothyroxine Sodium	83	24
Tramadol Hcl	Tramadol Hcl	83	16
Eliquis	Apixaban	82	11
Spironolactone	Spironolactone	80	27
Bupropion Xl	Bupropion Hcl	79	27
Duloxetine Hcl	Duloxetine Hcl	78	28
Donepezil Hcl	Donepezil Hcl	77	17
Fluticasone Propionate	Fluticasone Propionate	74	19
Trulicity	Dulaglutide	74	12
Irbesartan	Irbesartan	73	22
Lorazepam	Lorazepam	71	19
Tamsulosin Hcl	Tamsulosin Hcl	70	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	19
Sumatriptan Succinate	Sumatriptan Succinate	59	11
Memantine Hcl	Memantine Hcl	57	suppressed
Mirtazapine	Mirtazapine	56	14
Carvedilol	Carvedilol	55	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	15
Nifedipine Er	Nifedipine	46	14
Lovastatin	Lovastatin	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	12
Furosemide	Furosemide	43	12
Mounjaro	Tirzepatide	42	suppressed
Chlorthalidone	Chlorthalidone	41	13
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	suppressed
Valsartan	Valsartan	41	12
Albuterol Sulfate Hfa	Albuterol Sulfate	38	21
Alfuzosin Hcl Er	Alfuzosin Hcl	38	11
Hydralazine Hcl	Hydralazine Hcl	38	11
Januvia	Sitagliptin Phosphate	38	12
Finasteride	Finasteride	37	13
Methylprednisolone	Methylprednisolone	37	32
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	11
Azithromycin	Azithromycin	36	34
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	29
Farxiga	Dapagliflozin Propanediol	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Solifenacin Succinate	Solifenacin Succinate	34	13
Allopurinol	Allopurinol	32	suppressed
Glimepiride	Glimepiride	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Cephalexin	Cephalexin	30	20
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Atenolol	Atenolol	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	14
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	22
Verapamil Er	Verapamil Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	13
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Prolia	Denosumab	19	12
Ramipril	Ramipril	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Primidone	Primidone	18	suppressed
Savella	Milnacipran Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Glipizide	Glipizide	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Topiramate	Topiramate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Megestrol Acetate	Megestrol Acetate	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Trulance	Plecanatide	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Diazepam	Diazepam	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	11
Xarelto	Rivaroxaban	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Prednisone	Prednisone	13	suppressed
Serevent Diskus	Salmeterol Xinafoate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Yuvafem	Estradiol	12	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Estring	Estradiol	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error